Aemetis (AMTX) Projected to Announce Earnings on Thursday

Aemetis (NASDAQ:AMTXGet Free Report) will likely be issuing its Q2 2026 results before the market opens on Thursday, August 6th. Analysts expect Aemetis to announce earnings of ($0.29) per share and revenue of $67.6870 million for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, August 6, 2026 at 2:00 PM ET.

Aemetis (NASDAQ:AMTXGet Free Report) last released its quarterly earnings results on Thursday, May 7th. The specialty chemicals company reported ($0.33) earnings per share for the quarter, missing the consensus estimate of ($0.27) by ($0.06). The firm had revenue of $54.62 million during the quarter, compared to analysts’ expectations of $66.70 million. On average, analysts expect Aemetis to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Aemetis Price Performance

AMTX stock opened at $1.41 on Thursday. The company has a market cap of $99.22 million, a P/E ratio of -1.18 and a beta of 1.44. Aemetis has a 1 year low of $1.30 and a 1 year high of $3.80. The stock’s fifty day moving average price is $1.92 and its 200-day moving average price is $2.06.

Wall Street Analyst Weigh In

A number of research firms recently commented on AMTX. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research report on Friday, July 17th. Wall Street Zen downgraded Aemetis from a “hold” rating to a “sell” rating in a research note on Saturday, June 6th. Finally, Ascendiant Capital Markets boosted their price target on Aemetis from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $11.88.

Get Our Latest Analysis on AMTX

Institutional Investors Weigh In On Aemetis

Several hedge funds and other institutional investors have recently added to or reduced their stakes in AMTX. Creative Planning bought a new stake in Aemetis during the 2nd quarter worth approximately $30,000. Virtu Financial LLC purchased a new position in Aemetis during the fourth quarter valued at approximately $31,000. HRT Financial LP bought a new position in shares of Aemetis in the fourth quarter worth approximately $36,000. Centiva Capital LP purchased a new stake in shares of Aemetis in the third quarter worth $39,000. Finally, Engineers Gate Manager LP bought a new stake in shares of Aemetis during the 2nd quarter valued at $42,000. 27.02% of the stock is owned by hedge funds and other institutional investors.

About Aemetis

(Get Free Report)

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.

Featured Articles

Earnings History for Aemetis (NASDAQ:AMTX)

Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.